Literature DB >> 11810531

Influence of macrolides on guanosine diphospho-D-mannose dehydrogenase activity in Pseudomonas biofilm.

Y Mitsuya1, S Kawai, H Kobayashi.   

Abstract

The formation of biofilm is regarded as a major cause of intractable infectious disease. Our studies were done to elucidate the action of a 14-membered-ring macrolide (erythromycin; EM) and a 16-membered-ring macrolide (midecamycin; MDM) on guanosine diphospho-d-mannose dehydrogenase (GDP-mannose dehydrogenase; GMD), one of the constituents of bacterial biofilm that is known to produce alginate. The mucoid type of Pseudomonas aeruginosa PT-1578 and the non-mucoid type of P. aeruginosa PAO1 were grown with nutrient-rich and nutrient-poor media. Comparative measurements were made of their GMD enzyme activities, with glucose-6-phosphate dehydrogenase (G6PDH), a cell membrane enzyme, used as a control. It was found that the GMD enzyme activity of mucoid type of Pseudomonas bacteria increased when they were grown on nutrient-poor media. Measurements were also made to determine the effects of EM and MDM against GMD and G6PDH enzyme activities. In media with either EM or MDM added, the production of G6PDH was not inhibited, irrespective of the concentration of EM or MDM. However, EM was effective against the production of GMD, showing a concentration-dependent effect. Scanning electron microscopy studies were also carried out to determine the effects of both macrolides on bacterial alginate production. It was found that reduction of alginate content occurred after the addition of EM. When environmental conditions for bacteria deteriorate, GMD enzyme is activated, production of alginate is initiated, and then biofilm is formed. Our results suggest that EM may have an inhibitory effect on the GMD production cycle, hence inhibiting the formation of biofilm. This may explain the differences in the clinical usefulness of 14-membered-and 16-membered-ring macrolides against biofilm disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11810531     DOI: 10.1007/s101560050049

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  4 in total

Review 1.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 2.  Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?

Authors:  Paul King
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Characterization of Two Macrolide Resistance-Related Genes in Multidrug-Resistant Pseudomonas aeruginosa Isolates.

Authors:  Qing Chen; Wei Lu; Danying Zhou; Guotong Zheng; Hongmao Liu; Changrui Qian; Wangxiao Zhou; Junwan Lu; Liyan Ni; Qiyu Bao; Aifang Li; Teng Xu; Haili Xu
Journal:  Pol J Microbiol       Date:  2020-09-08

4.  Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa.

Authors:  Lan Lu; Yuting Zhao; Guojuan Yi; Mingxing Li; Li Liao; Chen Yang; Chihin Cho; Bin Zhang; Jie Zhu; Kun Zou; Qiang Cheng
Journal:  Chin Med       Date:  2021-08-06       Impact factor: 5.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.